No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients

Citations

WEB OF SCIENCE

20
Citations

SCOPUS

21

초록

Objective: This study investigated whether the brain-derived neurotrophic factor (BDNF) gene Val66Met single-nucleotide polymorphism (SNP) is associated with antipsychotic-induced tardive dyskinesia (TD) in schizophrenia. Methods: Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n=83) and without TD (n=126) who were matched for antipsychotic drug exposure and other relevant variables. Results: The frequencies of genotypes (chi(2)=2.37, p=0.306) and alleles (chi(2)=0.03. p=0.867) did not differ significantly between these two groups. Conclusion: These findings suggest that the BDNF polymorphism does not play a major role in the susceptibility to TD in schizophrenic patients. Crown Copyright (C) 2008 Published by Elsevier Inc. All rights reserved.

키워드

brain-derived neurotrophic factor; polymorphism; schizophrenia; tardive dyskinesia; RECEPTOR GENE; FAMILIAL OCCURRENCE; MESSENGER-RNA; BDNF GENE; RISK; EXPRESSION; CYP1A2
제목
No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients
저자
Kang, Seung-Gul; Choi, Jung-Eun; An, Hyonggin; Lim, Se-Won; Lee, Heon-Jeong; Han, Changsu; Kim, Yong-Ku; Kim, Seung-Hyun; Cho, Sung Nam; Lee, Min-Soo; Joe, Sook-Haeng; Jung, In-Kwa; Kim, Leen
DOI
10.1016/j.pnpbp.2008.05.016
발행일
2008-08-01
유형
Review
저널명
Progress in Neuro-Psychopharmacology and Biological Psychiatry
권
32
호
6
페이지
1545 ~ 1548